B-Cell and T-Cell Populations in Peripheral Blood Linked to Ocrelizumab Treatment Efficacy in Multiple Sclerosis

Response to ocrelizumab is linked to baseline regulatory and post-treatment effector B- and T-cell subset populations. Memory B-cells appear to be a marker of treatment efficacy for ocrelizumab.

Authors

Institutions

Publication Details

Journal
In Vivo
Published
2025-02-26
DOI
https://doi.org/10.21873/invivo.13920
Citations
1
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
1.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

B-Cell and T-Cell Populations in Peripheral Blood Linked to Ocrelizumab Treatment Efficacy in Multiple Sclerosis

Tijen Erdem, Aydın Ece, KIZILAY TUGCE, EROL RUZIYE et al.
1 citations
In Vivo
Chronic Lymphocytic Leukemia Research
1.63
article

B-Cell and T-Cell Populations in Peripheral Blood Linked to Ocrelizumab Treatment Efficacy in Multiple Sclerosis

Tijen Erdem, Aydın Ece, KIZILAY TUGCE, EROL RUZIYE, OZKAN YASARGUN DUYGU, YILMAZ VUSLAT, TÜRKOGLU RECAI
article en
1 citations

Abstract

Response to ocrelizumab is linked to baseline regulatory and post-treatment effector B- and T-cell subset populations. Memory B-cells appear to be a marker of treatment efficacy for ocrelizumab.

In VivoVol. 39(2)
Haydarpaşa Numune Eğitim ve Araştırma Hastanesi (TR), Istanbul Arel University (TR), Istanbul University (TR)
Openalex Percentile: Top 20%
Chronic Lymphocytic Leukemia Research
1.63
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.